Market Research Logo

Mexico Pharmaceuticals and Healthcare Report Q2 2016

Mexico Pharmaceuticals and Healthcare Report Q2 2016

BMI View: Mexico is one of the largest consumers of generic medicines in the world and is home to the second largest pharmaceuticals market in Latin America. The market size combined with an improving business environment makes the country an attractive prospect for foreign drugmakers

Headline Expenditure Projections

Pharmaceuticals: MXN177.3bn (USD11.2bn) in 2015 to MXN182.8bn (USD10.3bn) in 2016; +3.1% in local currency terms and -7.6% in US dollar terms.

Healthcare: MXN1,126.7bn (USD71.0bn) in 2015 to MXN1,194.0bn (USD67.5bn) in 2016; +6.0% in local currency terms and -5.0% in US dollar terms.


BMI Industry View
Table: Headline Pharmaceuticals And Healthcare Forecasts (Mexico 2014-2020)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Mexico 2012-2020)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Mexico 2012-2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Mexico 2012-2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Mexico 2012-2020)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Mexico 2012-2020)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Mexico 2012-2020)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Mexico 2012-2020)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Mexico 2012-2020)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Mexico 2014-2020)
Table: Pharmaceutical Trade Data And Forecasts local currency (Mexico 2014-2020)
Industry Risk Reward Index
Americas Risk/Reward Index
Mexico Risk/Reward Index
Rewards
Risks
Regulatory Review
Advertising
Intellectual Property Issues
Counterfeit Medicines
Pricing Regime
Reimbursement Regime
Market Overview
Healthcare Sector
Table: Healthcare Resources (Mexico 2010-2015)
Table: Healthcare Personnel (Mexico 2010-2015)
Table: Healthcare Activity (Mexico 2010-2015)
Table: List Of Hospitals In Mexico With Joint Commission International Accreditation
Research And Development
Clinical Trials
Epidemiology
Competitive Landscape
Research-Based Industry
Click here to enter text.
Table: Multinational Market Activity
Generic Drugmakers
Pharmaceutical Distribution
Pharmaceutical Retail Sector
Table: IMSS Financial Indicators, 2000-2011 (MXNmn)
Company Profile
Boehringer Ingelheim
Genomma Labs
Demographic Forecast
Demographic Outlook
Table: Population Headline Indicators (Mexico 1990-2025)
Table: Key Population Ratios (Mexico 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Mexico 1990-2025)
Table: Population By Age Group (Mexico 1990-2025)
Table: Population By Age Group % (Mexico 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report